Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients
An Israeli study identifies associations between the use of cannabinoids and terpenes for symptoms of attention deficit hyperactivity disorder (ADHD).
This category needs to be renamed to be meaningful than “Miscellaneous” but it will do for now. Basically it’s intended for news, research, legal actions and other information about medical marijuana for the general, nonexpert audience: patients, jouralists, the curious, etc.
Response to UK Medical Cannabis Guidelines
Physicians from the UK give their critiques of recent medical cannabis regulations, noting the narrow window of qualifying conditions that do not include chronic pain, as well as advocating for the use of lower-cost, whole-plant flowers for patients.
The Impact of Medical Cannabis on Intermittent and Chronic Opioid Users with Back Pain: How Cannabis Diminished Prescription Opioid Usage
A long-term observational study found cannabis worked as an alternative to prescription opioids in over half of patients with low back pain and an be an adjunct therapy to diminish chronic opioid use for some people.
Report from House of Representatives Hearing “Cannabis Policy – For The New Decade”
Dr. Patricia Frye summarizes a cannabis policy hearing at the House of Representatives. Dr. Frye saw strong bipartisan support for decreasing the barriers to research on cannabis medicine.
Update on the Vape Pen Crisis: Considerations for Healthcare Professionals
The SCC sent a poll to its membership to gauge how those within the organization were approaching the vape pen issue and EVALI. Learn more about their recommendations and considerations.
Medical students are unprepared to counsel patients about medical cannabis and want to learn more.
Complementary Therapies in Medicine, January 2020
—
Introduction: Over-the-counter and prescribed medical cannabis products are used by patients for various conditions including psychiatric disorders, pain management, and other neurodegenerative conditions.1 Despite this growing public interest and increasing legal availability…
IACM 2019 Highlights: Defending Doctors’ Rights Across the Globe
The 2019 IACM conference in Berlin highlighted talks from the top professionals in the field of cannabis science. Christine Milentis reports on the history of cannabis for medical use and the rights of doctors across the globe to prescribe it.
Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey.
A study published in BMC Family Practice sought to characterize the clinical practice characteristics of medical professionals who recommend cannabis.
Changing My Specialty
Dr. Sarah Mann tells the tale of one of her patients who inspired the shift towards a cannabis integrated practice.
Education, Knowledge, and Practice Characteristics of Cannabis Physicians
Kevin M. Takakuwa, MD and Dr. Dustin Sulak evaluate how US medical professionals received their cannabis medicine training in Mary Ann Liebert, Inc.
Cannabis and Sexual Health Survey
Genester Wilson-King, MD and Dr. Michael Eisenberg are conducting research on cannabis and sexual health at Stanford University. The survey will provide an opportunity for the general public to participate in cannabis research.
A History of the US Medical Cannabis Movement and Its Importance to Pediatricians
SCC member Kevin M. Takakuwa, MD outlines on the historical impact of cannabis and its relevance to pediatric practice. The article highlights how cannabis may benefit seizure disorders in children and young adults.